From Hit Identification to Lead Optimization: Building Scientific Continuity in Early Drug Discovery
As Dr. Bing Xia emphasized, hit identification is highly target-dependent and is not best approached as a fixed route. Strategy selection should begin with the target context, including biological ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results